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Summary The ribosome-inactivating proteins, bryodin, from Bryonia dioica, and momordin, from Momor-
dica charantia, were coupled by a disulphide bond to a monoclonal anti-Thy 1.1 antibody (OX7). Both
immunotoxins were specifically cytotoxic to the Thy 1.1-expressing mouse lymphoma cell* line AKR-A in
vitro. The OX7-bryodin immunotoxins were the more powerfully toxic and reduced protein synthesis in AKR-
A cells by 50% at a concentration of 1-4 x 10 -I M as compared with 1 x 0 -9M for the OX7-momordin
immunotoxins. Neither of the immunotoxins was toxic to mouse lymphoma EL4 cells, which lack the Thy 1.1
antigen, at concentrations up to 3 x 10-8M. Further, bryodin and momordin immunotoxins made from an
antibody (RIO) of irrelevant specificity were without effect on AKR-A cells.
An alternative to using toxin A-chains to form antibody-
toxin conjugates (immunotoxins) is to link single-chain
ribosome-inactivating proteins (RIPs) to the antibody. The
RIPs are plant proteins that are evolutionarily related to the
toxin A-chains and catalytically inactivate eukaryotic ribo-
somes by the same mechanism as the toxin A-chains
(Barbieri & Stirpe, 1982; Stirpe & Barbieri, 1986; Stirpe et
al., 1988). They offer the advantages over the toxin A-chains
for immunotoxin production that they are safer to handle in
quantity and do not need the same extensive purification to
exclude traces of B-chain which causes non-specific toxicity.
Further, the RIPs often do not cross-react immunologically
so that the sequential use of immunotoxins prepared with
different RIPs could avoid the problem of immunological
neutralization in vivo.
To date, RIP immunotoxins have been prepared with
gelonin, from Gelonium multiflorum (Thorpe et al., 1981;
Colombatti et al., 1983; Wiels et al., 1984; Lambert et al.,
1985; Scott et al., 1987a,b; Sivam et al., 1987), pokeweed
antiviral protein (PAP) from Phytolacca americana (Masuho
et al., 1982; Ramakrishnan & Houston, 1984a,b, 1985;
Uckun et al., 1985; Lambert et al., 1985) and saporin from
Saponaria officinalis (Thorpe et al., 1985; Letvin et al., 1986;
Glennie et al., 1987). In the present study, we describe the
preparation and properties of immunotoxins made by linking
the monoclonal anti-Thy 1.1 antibody OX7 to two other
RIPs: bryodin from the roots of Bryonia dioica (Stirpe et al.,
1986) and momordin, previously referred to as Momordica
charantia inhibitor (Barbieri et al., 1980). Immunotoxins
made with bryodin or momordin were both highly cytotoxic
to Thy 1.1-expressing cells in tissue culture but were unable
to inhibit protein synthesis in cells lacking the Thy 1.1
antigen.
Materials and methods
Materials
Seeds of M. charantia (bitter gourd) were the kind gift of
Professor J.-Y. Lin, Taipei, Taiwan. Roots of B. dioica
(white bryony) were obtained from the Botanic Garden of
the University of Bologna.
The hybridoma cell line MRC OX7 secreting a mouse
IgG, subclass antibody (OX7) to the Thy 1.1 antigen was
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provided by Dr A.F. Williams (University of Oxford, UK).
The hybridoma cell line LICR-LON-RIO secreting a mouse
IgGi subclass antibody (RIO) to human glycophorin was
supplied by Dr P.A. Edwards (Ludwig Institute, Sutton,
UK). The antibodies were purified from the blood and
ascitic fluid of hybridoma-bearing Balb/c mice by the
method of Mason and Williams (1980).
The Thy 1.1-expressing lymphoma cell line AKR-A was
obtained from Prof. I. MacLennan (Birmingham University,
Birmingham, UK). The Thy 1.2-expressing EL4 lymphoma
cell line was provided by Dr F. Spencer (Institute of Cancer
Research, Sutton, UK).
Sodium [125]iodide (IMS 30), L-[U-14C]leucine (CFB 67)
and L-[4,5-3H]leucine (TRK 170) were purchased from
Amersham International plc (Amersham, UK). lodo-gen was
from Pierce Ltd., (Chester, UK). N-succinimidyl 3-(2-
pyridyldithio)propionate (SPDP) was from Pharmacia Ltd.,
(London, UK). Reagents for measuring cell-free protein
synthesis and cell culture media were obtained from the same
sources as used previously (Thorpe et al., 1981).
Purification of RIPs
Bryodin was purified by the procedure described previously
(Stirpe et al., 1986) and appeared as a single protein band
(apparent Mr, 30,000) when analysed by SDS-PAGE.
Momordin was purified as previously (Barbieri et al., 1980)
except that the method was adapted to allow the processing
of 500g of seeds at a time. When examined by SDS-PAGE,
it appeared as a single protein band (apparent Mr, 31,000)
with traces of a contaminant protein with lower Mr. The
purified proteins were dialyzed extensively against water and
were freeze-dried and stored at -20°C.
Preparation of immunotoxins
The RIPs were dissolved in 50mM borate buffer titrated to
pH 9.0 with NaOH and the solution centrifuged to remove
any undissolved material. In order to quantify the amount of
RIP in the conjugated product, samples of the RIPs that had
been labelled with 125I by the lodo-gen method were added
to the protein before conjugation to give a final specific
activity of 0.855mCimg-1.
The RIPs were linked to the anti-Thy 1.1 monoclonal
antibody OX7 via a disulphide bond using the SPDP
reagent. The procedure was essentially that described pre-
viously for the synthesis of an anti-Thy 1.1-gelonin immuno-
toxin (Thorpe et al., 1981) with the modifications introduced
in the preparation of an OX7-saporin immunotoxin (Thorpe
Br. J. Cancer (1988), 58, 558-561SELECTIVE TOXICITY OF BRYODIN AND MOMORDIN IMMUNOTOXINS 559
et al., 1985). The RIP immunotoxins were separated from
the conjugation reaction mixture by gel filtration on a
column (100cmx2.2cm diameter) of Sephacryl S-200. For
each RIP, two species of conjugate were isolated: one, with
an Mr corresponding to between 180,000 and 210,000, had a
molar ratio of RIP:antibody of 1.0 to 1.5 (range of three
different preparations); the other, with an Mr greater than
210,000 had a molar ratio of RIP:antibody ranging from 1.5
to 1.8 (three different preparations). High and low Mr
immunotoxins consisting of bryodin or momordin and the
RIO antibody were prepared by an identical procedure.
Inhibition ofprotein synthesis in reticulocyte lysates
To determine the inhibitory activity of the RIP immuno-
toxins on cell-free protein synthesis, the conjugates in PBS
were first reduced with 50mM dithiothreitol (lh at 37°C) in
order to cleave the disulphide bond linking the RIP to the
antibody. It was shown previously that unreduced immuno-
toxins at RIP concentrations up 3.3 x 10-9 M did not signifi-
cantly affect protein synthesis (Thorpe et al., 1985). Protein
synthesis was measured by the incorporation of [14C]leucine
into trichloroacetic acid-precipitable material in rabbit reticu-
locyte lysates. The IC50 (the concentration of RIP or RIP
immunotoxin causing 50% inhibition) was calculated as
described previously (Thorpe et al., 1981).
Cytotoxicity experiments in tissue culture
The cytotoxic effects of the RIP immunotoxins were eval-
uated by measuring protein synthesis in cell cultures as
described previously (Thorpe et al., 1981). Two mouse T-cell
lymphoma lines were used: the Thy 1.1-positive AKR-A line
and the Thy 1.1-negative EL4 line. Cells were suspended at
5 x 104 cellsml-1 in RPMI 1640 medium containing 10%
(v/v) heat-inactivated foetal calf serum, 200U penicillinml-
and 100Hg streptomycin ml-1. The suspension was distri-
buted in 0.2ml volumes into 96-well flat-bottomed microtitre
plates. Substances to be tested were added at RIP concen-
trations ranging from 3.3x 10-14M to 3.3x 10-7M and the
plates were incubated at 37°C in an atmosphere of 5% CO2
in humidified air. After 24h, 1 ptCi of [3H]leucine was added,
and the radioactivity incorporated was measured after a
further 24h incubation (Thorpe et al., 1981).
Results
Inhibition of cell-free protein synthesis
Native bryodin and momordin exerted a powerful inhibitory
action on protein synthesis by a rabbit reticulocyte lysate.
Bryodin gave an IC50 of 4.5 x 10-I M consistent with the
value originally reported (Stirpe et al., 1986). The momordin
preparation used in these experiments had an IC50 of
2.2 x 10-10M, slightly higher than previously measured
(Barbieri et al., 1980). The capacity of 2-pyridyl-
dithiopropionylated bryodin to inhibit protein synthesis in
the reticulocyte lysate assay was almost entirely preserved
after conjugation to antibody (Table I). However, no inhibi-
Table I Effects of RIPs and RIP immunotoxins on protein
synthesis in a reticulocyte lysate
Materials IC50a(M)
Bryodin 4.5 x 10- II
2-Pyridyldithiopropionylated bryodin 9.1 x 10-1
OX7-bryodin, low Mr conjugateb 1.0 x 10- 10
OX7-bryodin, high Mr conjugateb 1.3 x 10- 10
Momordin 2.2 x 10 10
2-Pyridyldithiopropionylated momordin 5.4 x 10- 10
OX7-momordin, low Mr conjugateb 1.0 x 10-9
OX7-momordin, high Mr conjugateb 1.1 x 10-9
aIC50=concentration calculated to reduce protein synthesis
by 50%; bAfter reduction with dithiothreitol.
tory activity could be detected unless the bryodin immuno-
toxins were first treated with dithiothreitol to split the
disulphide bond suggesting that, in common with immuno-
toxins made with gelonin (Thorpe et al., 1981) and saporin
(Thorpe et al., 1985), the RIP must be released from the
antibody before it can catalytically inactivate ribosomes. In
contrast with bryodin, momordin that had been attached to
antibody retained only one-fifth of the ribosome-inactivating
activity of native momordin (Table I) indicating that the
effect of introducing 2-pyridyldithiopropionyl groups into
the RIP reduced its activity by 80%.
Toxicity to lymphoma cells in tissue culture
OX7-bryodin immunotoxins with low and high Mr were
both highly toxic to the Thy 1.1-expressing lymphoma cell
line AKR-A. In a representative experiment shown in Figure
1 a, both these conjugates halved the incorporation of
[3H]leucine into the AKR-A cells at a concentration of less
than 5 x 10-I M. Unconjugated bryodin had the same toxic
effect only at much higher concentration, 2 x 10-7 M, indica-
ting that the cytotoxicity of the RIP to AKR-A cells was
enhanced at least 4,000-fold by attachment to the anti-Thy
1.1 antibody.
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Figure 1 Cytotoxic effects of OX7-bryodin and OX7-momordin
immunotoxins to AKR-A cells in vitro. (a) AKR-A lymphoma
cells were incubated continuously in tissue culture with OX7-
bryodin, low Mr conjugate (0), OX7-bryodin, high Mr conju-
gate (l) or with unconjugated bryodin (A) for 48h; (b) AKR-A
lymphoma cells were cultured in the presence of OX7-momordin,
low Mr conjugate (R), OX7- momordin, high Mr conjugate (El)
or unconjugated momordin (A). Each point represents the
geometric mean of triplicate measurements of [3H]leucine incor-
poration by cells during the final 24h period of culture. Standard
deviations on the points were < + 10% of the mean value. Mean
[3H]leucine incorporation in untreated cultures was -40,000
d.p.m.
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Table II Cytotoxic effects of immunotoxins made with bryo-
din or momordin
IC50"a(M) Cell lines
Materials
Bryodin
OX7-bryodin (low Mr)
OX7-bryodin (high Mr)
RIO-bryodin (low Mr)
R1O-bryodin (high Mr)
AKR-,
1.7 x 10-
1.2 x 10-
3.7 x 10-
>3.3 x 10-
>3.3 x 10-
Momordin >3.3x10-
OX7-momordin (low Mr) 1.2 x 10-
OX7-momordin (high Mr) 7.7 x 10-
RIO-momordin (low Mr) >3.3 x 10-
R1O-momordin (high Mr) >3.3 x 10-
OX7-ricin A
Ricin
A EL4
-7 (4) >3.3x10-7 (3)
-11 (4) >3.3 x 10 8 (2)
-11 (4) >3.3 x 10 8 (2)
8 (1) NDb
-8(1) ND
-17 (2) >3.3xl10-7 (2)
(2) >3.3 x 10 (2)
-10(2)>3.3x10 7 (2)
-8(1) ND
-8(1) ND
1.1 xl 1(5) >3.3 x10-8 (3)
2.2x 10- 11(8) 8.2x 101-2 (3)
aIC =concentration calculated to reduce [3H]leucine
incorporation by 50% in experiments such as shown in Figure
1; bND =not determined. The values quoted represent a
single determination or the mean value of several experi-
ments. The number of experiments is given in brackets after
the value.
In several experiments, the low Mr OX7-bryodin conju-
gate was consistently found to be about 3-fold more toxic to
the AKR-A cells than the high Mr OX7-bryodin conjugate
(0.1>P>0.05) and some 20,000-fold more toxic than bryo-
din itself (Table II). The cytotoxic effect of the low Mr
bryodin immunotoxin was virtually identical with that mea-
sured for an OX7-ricin A-chain immunotoxin in the same
series of experiments and slightly greater than the cytotoxi-
city of ricin (Table II).
The cytotoxic action of both bryodin immunotoxins was
cell type-specific. Both demonstrated a slight (< 10%) inhibi-
tion of protein synthesis in the Thy 1.1-negative lymphoma
cell line EL4 at the highest concentration tested, 3 x 10-8 M,
and this effect was identical with that given by native
bryodin on EL4 cells at the same concentration. Further,
neither unconjugated OX7 monoclonal antibody nor control
conjugates made from the RIO antibody of irrelevant specifi-
city linked to bryodin using SPDP showed any significant
toxicity to AKR-A cells at high concentration (Table II).
The OX7-momordin immunotoxins were also selectively
cytotoxic to Thy 1.1-positive cells although much less effec-
tive than the bryodin immunotoxins. Both the low and high
Mr momordin immunotoxins inhibited the uptake of
[3H]leucine by AKR-A cells by 50% at a concentration of
about I x 10 -9M (Figure Ib). Native momordin had the
same toxic effect at a concentration slightly above 3 x 10- M
indicating only an approximate 300-fold enhancement of
RIP toxicity as a result of conjugation to the anti-Thy 1.1
antibody. However, whereas the bryodin immunotoxins inhi-
bited [3H]leucine incorporation by 95% at a concentration of
3 x 10-9M, the momordin immunotoxins failed to diminish
[3H]leucine incorporation by more than about 70-80% even
at saturating concentrations of immunotoxin between
3 x 10-9 M and 3 x 10 - 7 M, suggesting that a greater
proportion of AKR-A cells survived exposure to the momor-
din immunotoxins.
Discussion
Bryodin and momordin, two plant proteins that powerfully
inhibit protein synthesis by eukaryotic ribosomes in a reticu-
locyte lysate assay, were linked to the OX7 monoclonal
antibody recognising the mouse Thy 1.1 antigen using the
SPDP reagent which introduces a disulphide linkage. The
OX7-bryodin immunotoxins were powerfully and specifically
toxic to Thy 1.I-expressing mouse AKR-A cells in tissue
culture. They had similar potency of cytotoxic effect to
immunotoxins prepared previously by attaching PAP
(Ramakrishnan & Houston, 1984a,b), saporin (Thorpe et al.,
1985), ricin A-chain (Blythman et al., 1981) or abrin A-chain
(Thorpe et al., 1987) to monoclonal antibodies recognising
the Thy 1.1 antigen. By contrast, the OX7-momordin immu-
notoxins were 20- to 100-fold less toxic to AKR-A cells than
the bryodin immunotoxins. This was probably due, in part,
to the 10-fold lower ribosome-inactivating activity of conju-
gated momordin (IC50, 1 x 10-9M) compared with conju-
gated bryodin (IC50, 1 x 101 M). Also, conjugated
momordin may penetrate cellular membranes less efficiently
and so kill cells more slowly than other RIPs or toxin A-
chains that form potent immunotoxins. A slow rate of cell
intoxication would explain the survival of 20-30% of AKR-
A cells exposed to saturating concentrations of OX7-
momordin immunotoxins. It is possible that AKR-A cells
treated with OX7-momordin for a longer period of time
would eventually have been killed as previously observed
with a human lymphoblastoid cell line treated with a gelonin
immunotoxin (Lambert et al., 1985).
The cell-free ribosome-inactivating activity of bryodin or
momordin was reduced about 2-fold and 5-fold respectively
when they were reacted with SPDP during the coupling
procedure. We have since found that this loss in activity is
not seen when 2-iminothiolane (21T) is used as the crosslink-
ing reagent (unpublished results). In accordance with these
results, Lambert et al., (1985) reported that gelonin was not
inactivated when thiol groups were introduced using 2IT
whereas, as we previously reported (Thorpe et al., 1981), the
reaction of gelonin with SPDP reduced its activity 5-fold. It
is possible that SPDP (but not 21T) reacts preferentially with
amino groups in the RIPs that are essential for expression of
ribosome-inactivating activity. Alternatively, the catalytic
activity may be better preserved after reaction with 21T
because the amino groups which are modified retain their
positive charge (Wawrzynczak & Thorpe, 1988). It is there-
fore likely that bryodin or momordin immunotoxins
prepared using 21T instead of SPDP would show even
greater cytotoxic potency than those used in the present
report.
The anti-tumour activity of an anti-Thy 1.1-momordin
immunotoxin was previously shown to be 10-fold better than
that given by an equal dose of a Thy 1.1-ricin A-chain
immunotoxin in a mouse AKR-A tumour model system
despite its inferior cytotoxicity in vitro (Blakey et al., 1987b).
The weaker anti-tumour activity of ricin A-chain immuno-
toxins has been attributed principally to two factors which
may not be a problem with momordin immunotoxins.
Firstly, ricin A-chain bears oligosaccharide chains of a type
that are recognised by the liver and mediate the rapid
clearance of ricin A-chain immunotoxins from the blood-
stream (Blakey & Thorpe, 1988). In contrast, the oligosac-
charide reported to be present on momordin (Falasca et al.,
1982) is not of a type that evokes rapid hepatic clearance.
Secondly, ricin A-chain immunotoxins break down in vivo to
antibody and A-chain (Blakey et al., 1987a). Both momordin
and bryodin immunotoxins, in common with saporin immu-
notoxins (Thorpe et al., 1985), may have better in vivo
stability because these RIPs are positively charged at neutral
pH and, as hypothesised for saporin immunotoxins, they
may interact non-covalently with the negatively charged
antibody molecule to shield the disulphide bond from
cleavage by thiol-containing compounds or proteins in the
animal.
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